Review

Get Permission
Rev Diabet Stud, 2011, 8(2):230-244 DOI 10.1900/RDS.2011.8.230

Association Between Genetics of Diabetes, Coronary Artery Disease, and Macrovascular Complications: Exploring a Common Ground Hypothesis

André G. Sousa1,2, Lívia Selvatici1, José E. Krieger1, Alexandre C. Pereira1

1Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
2Clinical Medicine Department, Federal University of Rio Grande do Norte, Natal, Brazil
Address correspondence to: Alexandre C. Pereira, e-mail: alexandre.pereira@incor.usp.br

Manuscript submitted June 6, 2011; resubmitted July 28, 2011; accepted August 1, 2011.

Keywords: diabetes, coronary artery disease, HLA, polymorphism, genome-wide association study

Abstract

Type 2 diabetes and coronary artery disease (CAD) are conditions that cause a substantial public health burden. Since both conditions often coexist in the same individual, it has been hypothesized that they have a common effector. Insulin and hyperglycemia are assumed to play critical roles in this scenario. In recent years, many genetic risk factors for both diabetes and CAD have been discovered, mainly through genome-wide association studies. Genetic aspects of diabetes, diabetic macrovascular complications, and CAD are assumed to have intersections leading to the common effector hypothesis. However, only a few genetic risk factors could be identified that modulate the risk for both conditions. Polymorphisms in TCF7L2 and near the CDKN2A/B genes seem to be of great importance in this regard since they appear to modulate both conditions, and they are not necessarily related to insulinism, or hyperglycemia, for CAD development. Other issues related to this hypothesis, such as the problems of phenotype heterogeneity, are also of interest. Recent studies have contributed to a better understanding of the complex genetics of diabetic macrovascular complications. Much effort is still needed to clarify the associations in the genetics of diabetes, and cardiovascular disease. At present, there is little genetic evidence to support a common effector hypothesis, other than insulin or hyperglycemia, for the association between these conditions.

Fulltext: HTML , PDF (352KB)


This article has been cited by other articles:

Activation of Wnt/β-catenin/GSK3β signaling during the development of diabetic cardiomyopathy

Xi XH, Wang Y, Li J, Wang FW, Tian GH, Yin MS, Mu YL, Chong ZZ

Cardiovasc Pathol 2014. pii:S1054-8807(14)00161-6

Pattern of macrovascular disease phenotypes amongst newly diagnosed type 2 diabetic patients in a rural institute in Uttar Pradesh, India

Verma VK, Singh PS, Yadav RK, Kumar M, Zafar KS, Rawat R

Int J Res Med Sci 2014. 2(3):932-940

Cardiovascular and Kidney Disease Traits - Pleiotropic or Just Polygenic?

Rao M

Am J Kidney Dis 2013. 61(6):851-854

Coronary Heart Disease and Emotional Intelligence

Vlachaki C, Maridaki Kassotaki K

Glob J Health Sci 2013. 5(6):156-165

Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: a proof of principle on type 2 diabetes

Garagnani P, Giuliani C, Pirazzini C, Olivieri F, Bacalini MG, Ostan R, Mari D, Passarino G, Monti D, Bonfigli AR, Boemi M, Ceriello A, Genovese S, Sevini F, Luiselli D, Tieri P, Capri M, Salvioli S, Vijg J, Suh Y, Delledonne M, Testa R, Franceschi C

Aging (Albany NY) 2013. 5(5):373-385

Macrovascular complication phenotypes in type 2 diabetic patients

Papa G, Degano C, Iurato MP, Licciardello C, Maiorana R, Finocchiaro C

Cardiovasc Diabetol 2013. 12:20

Genetic Links between Coronary Artery Disease and Type 2 Diabetes

Vats A, Sambyal V, Bhanwer AJ

Hum Biol Rev 2013. 2(2):90-119

Urinary albumin excretion rate is correlated with severity of coronary artery disease in elderly type 2 diabetic patients

Guo LX, Ma J, Cheng Y, Zhang LN, Li M

Chin Med J (Engl) 2012. 125(23):4181-4184